Japan· JP-1124010F1030
ロルメタゼパム
A lormetazepam product containing ロルメタゼパム, registered in Japan by あすか製薬, on the national reimbursement list. The same ATC class is registered in 9 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Lormetazepam is registered in 9 of 19 countries.
Countries holding a registration under ATC N05CD06 (lormetazepam), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 5 of them publish a price we can compare per daily dose
Lormetazepam · ATC N05CD06
9 / 19 countries
- Belgiumprice
- Franceprice
- Germany
- Japan
- Netherlands
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of lormetazepam costs, country by country.
Normalised to the WHO defined daily dose (1 mg), the median price runs from $0.066 in Spain to $0.58 in Switzerland — a ×8.9 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Lormetazepam · price per daily dose (1 mg)
USD · FX 28 Sept 2026
- CH Switzerland$0.58
- FR France$0.068
- ES Spain$0.066
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- ロルメタゼパム
- Manufacturer
- あすか製薬
- Country
- Japan (JP)
- ATC code
- N05CD06
- ATC class
- Lormetazepam
- Defined daily dose
- 1 mg, O
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
44 interactions on record for lormetazepam.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Lormetazepam · interactions on record
44 records
44 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame class
Other records under N05CD06
Lormetazepam, as other registers publish it.
- SpainALDOSOMNIL 1 mgLaboratorio Aldo Union S.L.
- SpainALDOSOMNIL 2 mgLaboratorio Aldo Union S.L.
- GermanyErgocalmTeofarma S.R.L.
- BelgiumLoramet 1 mgViatris Healthcare
- SpainLORAMET 1 mg COMPRIMIDOSViatris Healthcare Limited
- SwitzerlandLoramet 1,0, TablettenViatris Pharma GmbH
- SwitzerlandLoramet 1,0, TablettenViatris Pharma GmbH
- BelgiumLoramet 2 mgImpexeco
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ce9c0e4f-81b2-4156-97ce-464b3924e9d3 GET /v1/drugs/ce9c0e4f-81b2-4156-97ce-464b3924e9d3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "１ｍｇ１錠",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "1124010F1030",
"category": "内用薬",
"price_yen": 12.5,
"generic_name": "ロルメタゼパム",
"product_name_jp": null,
"therapeutic_class": "1124",
"transitional_expiry": null
}See everything about lormetazepam.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.